Connect with us

Financial News

Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket

Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket

Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.Read More

More in Financial News